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Abstract
Background: Livestock-Associated MRSA (LA-MRSA) belonging to ST398 lineage, common among pigs and other
animals, emerged in Central and Northern Europe, becoming a new risk factor for MRSA among farm workers.
Strains belonging to ST398 can be responsible for human colonization and infection, mainly in areas with high
livestock-farming. The aim of this study was to investigate the occurrence of livestock-associated methicillin-
resistant Staphylococcus aureus (LA-MRSA) human colonization and infections in an area of the Lombardy Region
(Italy), the Italian region with the highest density of pig farming.
Methods: In the period March-April 2010, 879 nasal swabs were taken from subjects at admission to a local
hospital serving an area of the Lombardy Region devoted to agriculture and farming. In the period March 2010-
February 2011, all MRSA strains from community-acquired infection (CAI) observed in the same hospital, were
collected. Molecular characterization of the isolates included SCCmec typing, spa typing and multilocus sequence
typing (MLST).
Results: Out of 879 nasal swabs examined, 9 (1%) yielded MRSA. Five strains were assigned to sequence type (ST)
398 (spa t899, 3 isolates; t108 and t2922, 1 isolate each) and were therefore categorized as LA-MRSA. The other 4
isolates were likely of hospital origin. No strains were positive for Panton-Valentine Leukocidin genes. Twenty MRSA
isolates were detected from CAI, 17 were from skin and soft-tissue infections and 3 from other infections. An MRSA
isolate from otitis externa was t899/ST398 and PVL-negative, hence categorized as LA-MRSA. Four isolates were
assigned to t127/ST1. Eight strains were PVL-positive community acquired (CA)-MRSA and belonged to different
clones, the most frequent being ST8.
Conclusions: In an area of Italy with high density of pig farming, LA-MRSA is able to colonize the population and
rarely to produce infections. Typical CA-MRSA is more common than LA-MRSA among CAI.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) emerged
in hospital fifty years ago and swiftly became one of the
most important hospital-associated (HA) pathogens being
responsible for serious infections such as pneumonia and
sepsis [1], and commonly characterized by a multi-drug
resistant phenotype. Distinct lineages of HA-MRSA
emerged in the years and became established with diffe-
rent success in different geographical locations [2].
Starting from the last decade, MRSA epidemiology
largely changed, due to the emergence of new MRSA
lineages, responsible for infections occurring in the com-
munity among patients without known risks factors for
the acquisition of MRSA and without previous hospital
contacts [3]. These strains, defined community acquired
(CA)-MRSA, are mainly responsible for skin and soft-
tissue infections (SSTI), although deep-seated infections
such as necrotizing pneumonia, sepsis and meningitis,
have also been reported [3,4]. CA-MRSA is character-
ized by the presence of the Panton-Valentine Leukocidin
(PVL), a toxin that causes polymorphonuclear lysis and
tissue necrosis [5] although its contribution to disease is
still debated [6,7].
More recently, the emergence of an MRSA clone colo-
nizing pigs and, more rarely, other farm animals (cattle
and poultry) have been reported in Europe [8-10]. These
strains, designated livestock-associated (LA)-MRSA and
belonging to sequence type (ST)398, were mostly found in
countries with high density of pig farming such as the
Netherlands, Denmark and Germany [11,12]. These
strains were able to colonize persons working in close
contact with pigs, such as farmers and veterinarians.
In Netherland and in Germany, 26.5% and 24% of pig
farmers were colonized by LA-MRSA, respectively [12,13].
Wulf et al. found that 12.5% of veterinarians attending
an international conference were colonized by MRSA of
which 92.5% were LA-MRSA [14]. Farmers’ family mem-
bers, who are not in direct contact with pigs, were co-
lonized at a lower frequency than the farm workers,
indicating that inter-human transmission may occur [15].
Since LA-MRSA was found in dust from pig holdings
[16], the environment could represent a vehicle for the
transmission of LA-MRSA strains from animals to humans,
allowing colonization of subjects who do not work directly
with animals.
Infections due to LA-MRSA have been reported occa-
sionally in farm workers and their family members [10]. In
the Netherlands and Denmark where the percentage
of HA-MRSA is very low (<1%), LA-MRSA strains repre-
sent an important reservoir for human MRSA infections
[10,11]. In the Netherland, by the end of 2008, LA-MRSA
ST398 accounted for 42% of all new detected MRSA [12].
In Italy, LA-MRSA ST398 prevalence in farm workers is
unknown. In the study previously cited, MRSA carriage in
Italian veterinarians was found to be 54% [14]. Two cases
of serious infections due to LA-MRSA were described in
Italian farmers in the Lombardy region: a man working on
a pig farm who developed cellulitis and pyomiositis of the
buttock and a man working on a dairy farm who deve-
loped necrotizing fasciitis of the neck [17,18].
Other MRSA lineages different from ST398 were found
in a European survey on the prevalence of MRSA in pig
holdings. One lineage, characterized by spa type t127 and
belonging to ST1 was predominantly reported from Italy
[16], as shown also by other studies [19]. Franco et al.
recently demonstrated that t127/ST1 isolates can be
assigned to two genetically different clusters (porcine and
human) and hypothesized that t127/ST1 strains could rep-
resent another lineage of LA-MRSA [20].
This study was undertaken to investigate the preva-
lence of LA-MRSA colonization and the occurrence of
LA-MRSA infections in subjects living in an area of the
Lombardy region, where livestock farming is a promi-
nent activity.
Methods
Setting of the study and source of isolates
Two prospective studies were performed: a study on
MRSA colonization in patients at hospital admission and
a study on MRSA in community-acquired infections
(CAI). Both studies were conducted at the Manerbio
Hospital, a local hospital with 250 beds, serving a popu-
lation of approximately 120.000 inhabitants. This area
was chosen for the studies because a case of LA-MRSA
infection was detected in 2008 [18], and because live-
stock farming is one of the main economical activities of
this area, located in Lombardy, the region with the
highest pig farming density in Italy (Figure 1) [21].
For the colonization study, in the period March-April
2010, all subjects presenting to the hospital for pre-
admission laboratory tests before planned surgery, were
subjected to a nasal swab for MRSA screening. Swabs
were plated onto Mannitol Salt agar and Brilliance MRSA
agar plates (Thermo Fisher Scientific, Milan, Italy). No en-
richment culture was performed. The isolates were identi-
fied using an automated system (Vitek2, bioMérieux,
Marcy-l’Etoile, France) at the Manerbio Hospital labo-
ratory. Interpretative criteria were those suggested by the
Clinical and Laboratory Standards Institute (CLSI) [22].
The study on CAI was conducted from March 2010 to
February 2011. The definition of CAI included infections
in outpatients and in hospitalized patients, within 48 h
from hospital admission, who had not been hospitalized
in the previous 3 months. MRSA strains originating
from CAI were collected and further characterized. Only
the first MRSA isolate per patient was studied.
Nasal screening was part of the pre-admission routine
tests for surgical patients at the hospital involved in the
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study. Patients gave informed consent to the surgical
procedure. Clinical data and samples (bacterial isolates)
were anonymised before being used for the study. The
study was exempt from Ethics Committee approval
according to local and national regulations.
Antimicrobial susceptibility testing
In vitro susceptibility tests were obtained by an automated
system (Vitek2, bioMérieux, Marcy-l’Etoile, France). The
antimicrobial agents tested included: oxacillin, gentamicin,
levofloxacin, erythromycin, clindamycin, tetracycline, ri-
fampicin, vancomycin, teicoplanin, tigecycline, linezolid,
trimethoprim-sulfamethoxazole, fusidic acid and mupirocin.
Interpretative criteria were those suggested by the CLSI [22].
Molecular characterization of the isolates
Genomic DNA of MRSA isolates was extracted by the
QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany)
and used as a template for polymerase chain reaction
(PCR) amplification. S. aureus species and methicillin
resistance status were confirmed by a duplex PCR
targeting the genes nuc and mec. This PCR assay was
developed in our laboratory by using primers published
by Brakstad O.G et al., and Murakamy K., et al. [23,24].
The detection of the Panton-Valentine leukocidin (PVL)
and of the arginine catabolic mobile element (ACME)-
specific arcA gene were performed as previously
described [25]. The sak gene, encoding the plasminogen
activator staphylokinase, was investigated on t127 strains
by using published primers [26].
To determine the Staphylococcal chromosomal cassette
mec (SCCmec) type, a combination of different multiplex
PCR assays, discriminating the mec complex and the ccr
genes complex, were applied by using protocols previously
described [25]. Subtyping of the SCCmec type IV was
obtained applying the method described by Milheiriço C.,
et al. [27].
Amplification, sequencing and analysis of the poly-
morphic region of the protein A gene (spa typing) was
performed according to the standard protocol of Harmsen
et al. [28]. MLST was performed on selected strains as de-
scribed elsewhere [29]. The allelic profiles obtained were
compared to those present in the MLST database.
Results
In the colonization study, 9 out of 879 patients (1%)
subjected to nasal screening prior to hospitalization were
positive for MRSA. The age of patients carrying MRSA
ranged from 17 to 71 years (median age 58); 4 patients
were females and 5 were males. Out of the 9 patients
colonized, 5 (56%) carried LA-MRSA ST398. The overall
LA-MRSA colonization rate was 0.56%.
The characteristics of the MRSA isolates are shown in
Table 1. The 5 LA-MRSA strains were t899/SCCmec type
IVa (2 isolates), t899/SCCmec IVc (1 isolate), t108/SCCmec
type V (1 isolate) and t2922/SCCmec type V (1 isolate).
The other isolates obtained from carriage belonged ST8
(3 isolates) and ST5 (1 isolate). None of the colonizing
strains was positive for PVL genes.
In the infection study, 20 CAI due to MRSA were
detected in the span of one year. Thirteen patients were
females and 7 were males. The age of patients ranged
from 8 months to 85 years (median age 53). Out of the
20 isolates, 17 were obtained from SSTI, 2 from otitis
externa and 1 from bloodstream infection. One of the
isolates from otitis externa was t899/ST398/SCCmec IVc
and was categorized as LA-MRSA. Eight strains were
positive for PVL and were considered typical CA-
MRSA. Of these, 3 were t008/ST8/SCCmec IVa and
ACME-positive and therefore most likely corresponding
to the USA300 clone. Another strain was t044/ST80/
SCCmec IVc and belonged to the European clone, while
3 other strains belonged to other lineages (ST22, ST772
and ST1).
ST8 and ST1 were found among both PVL-positive and
PVL-negative isolates. PVL-negative ST8 were negative
for ACME, too. All ST1 isolates (4 strains), belonged to
spa type t127 and harboured the sak gene; of these one
carried also PVL. The PVL-positive t127 isolate carried
SCCmec V while the 3 PVL-negative t127 isolates carried
SCCmec IVa.
Figure 1 Density of breeding and fattening pigs in Italy.
Adapted from [21]. The open circle indicates the area in the
Lombardy Region where the study was performed.
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All the isolates, both from colonization and infections,
were fully susceptible to vancomycin, teicoplanin, linezolid,
tigecycline and mupirocin. All ST398 isolates were
resistant to tetracycline. Resistance profiles to other
non-beta-lactam antibiotics are shown in Table 1.
Discussion
In the present study we examined MRSA strains obtained
from nasal screening of subjects prior to hospital admission
and MRSA strains from CAI in an Italian Region,
Lombardy, with the highest density of pig farming in Italy
(48.2% of all the pigs reared in the country) [21]. In particu-
lar, in the area where the study was conducted, a serious
case of LA-MRSA infection was identified in 2008 [18].
Although the number of MRSA isolates obtained in this
study was small, two different pictures emerged clearly:
LA-MRSA, belonging to ST398, was prevalent (56%)
among the admission screening MRSA isolates, while,








SCCmec type spa type ST CC PVL ACME Resistance pattern to
non beta-lactam antibiotics§
Colonization
Sau93 M 67 - IVc t899 398 398 - - ERY, CLI, SXT, TET
Sau95 F 77 - IVa t899 398 398 - - ERY, CLI, TET
Sau98 F 58 - IVa t899 398 398 - - TET
Sau91 M 40 - V t108 398 398 - - LVX #, TET
Sau99 M 20 - V t2922 398 398 - - ERY, CLI, SXT, TET
Sau96 F 61 - IVc t008 8 8 - - LVX, TET
Sau97 M 66 - IVc t008 8 8 - - GN, LVX
Sau92 M 71 - IVc t008 8 8 - - LVX
Sau94 F 17 - V t688 5 5 - - ERY, CLI*, TET
Infections
Sau150 M 18 SSTI IVa t008 8 8 + + LVX, ERY
Sau116 F 71 SSTI IVa t008 8 8 + + LVX, ERY
Sau161 F 27 SSTI IVa t008 8 8 + + LVX, ERY
Sau85 F 46 SSTI IVa t121 8 8 + - LVX, ERY
Sau86 F 35 SSTI IVc t005 22 22 + - ERY, CLI*
Sau149 M 0.8 SSTI IVc t044 80 80 + - FUS, TET
Sau151 F 2 SSTI V t127 1 1 + - GN, FUS, TET
Sau119 M 38 SSTI V t7445 772 1 + - GN, ERY, CLI* SXT,
Sau118 F 53 SSTI IVc t008 8 8 - - LVX #,
Sau73 F 70 SSTI IVc t008 8 8 - - LVX #, ERY, CLI*
Sau159 F 85 SSTI IVc t008 8 8 - - LVX
Sau163 F 53 SSTI IVc t008 8 8 - - GN, LVX, RIF
Sau84 M 67 SSTI IVc t008 8 8 - - LVX, TET
Sau121 F 83 BSI IVc t008 8 8 - - LVX
Sau82 F 84 SSTI IVa t127 1 1 - - LVX, ERY, CLI*
Sau83 F 9 SSTI IVa t127 1 1 - - ERY, CLI*, TET
Sau162 F 61 OE IVa t127 1 1 - - GN, ERY, CLI*, TET
Sau120 M 77 SSTI IVh t515 22 22 - - LVX #
Sau117 M 79 SSTI I t041 228 5 - - GN, LVX, ERY, CLI, RIF#
Sau74 M 68 OE IVc t899 398 398 - - CLI, SXT, TET
SCCmec staphylococcal cassette chromosome mec, ST sequence type, CC clonal complex, PVL Panton-Valentine Leukocidin, ACME arginine catabolic
mobile element.
§ GEN gentamicin, ERY erythromycin, CLI clindamycin, LVX levofloxacin, FUS fusidic acid, TET tetracycline, SXT co-trimoxazole, RIF rifampicin, * inducible
clindamycin resistance; # intermediate resistance.
SSTI skin and soft tissue infection, BSI bloodstream infection, OE otitis externa.
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among the infections typical PVL-positive CA-MRSA pre-
dominate and only one strain belonging to ST398 was
found. The percentage of LA-MRSA out of all MRSA
colonizing strains is similar to that found in patients at ad-
mission to hospital in a region with high density of animal
farming in Germany [30].
Unfortunately we were unable to obtain precise infor-
mation about the working activity of the colonized
subjects or of the infected patients, therefore we do not
know if any of them worked or lived in close contact
with pigs or other farm animals. The overall percentage
of ST398 colonization in our study (0.56%) is in the
range (from <0.01 to 1.2%) described in the Netherlands
and Germany, regarding non-exposed healthy popu-
lation [12,13].
Our study confirms that the presence of LA-MRSA in
human infections is rare. LA-MRSA isolates have been
reported to sporadically cause mild or serious infections
and a hospital outbreak [17,18,31,32]. According to data
reported by Van Cleef et al., MRSA ST398 clone
contributes only to a small fraction (<2%) of all MRSA
isolates in humans [9]. In a framework of an European
survey conducted in 2011 on invasive infections caused
by S. aureus predominant clones, we found that in Italy
1 out of 97 MRSA (1.5%) strains belonged to a spa type
indicative of ST398 (unpublished data), while in a previ-
ous survey carried out in 2006 no ST398 was found [2].
Therefore the ability of LA-MRSA to cause infections
appears to be limited. This is probably due to the lack or
rare occurrence of specific virulence factors, such as
toxic shock syndrome toxic-1 (TSST-1) toxin and PVL,
as shown by microarray and genomic studies [33,34]. In
addition, LA-MRSA lacks the cluster of genes for human-
specific immune evasion encoded by Saϕ3 bacteriophage,
and therefore is less virulent in humans than other
staphylococcal clones [34,35].
In our study on outpatient infections, a prominent role
was played by typical CA-MRSA strains. The presence
of a variety of CA-MRSA clones including USA300, has
been observed, as already reported in other studies
[4,25,36].
The recovery of isolates belonging to t127/ST1 is intri-
guing. t127/ST1 strains were recently isolated from pigs
in Italy and the presence of a pig reservoir of this lineage
has been hypothesized [20]. In the study by Franco
et al., the t127 strains of porcine origin carried SCCmec
type V, while the t127 isolates of human origin har-
boured SCCmec type IVa and carried the sak gene, an
immune-evasion factor present almost exclusively in
human strains [20]. In our study three t127 strains
carried SCCmec type IVa and the sak gene, indicating
human origin. The only strain carrying SCCmec type V
also harbored sak and PVL and therefore its porcine or
human origin cannot be hypothesized.
Other clones causing infections are likely of hospital
origin, such as the PVL-negative ST8 clone, resembling
the “Lyon clone”, a well adapted hospital clone that
emerged in France and spread in other European coun-
tries, including Italy [37,38]. The presence of HA-MRSA
in infections in the community might be due to previous
contact of the patients with health-care settings.
Conclusion
Italy is one of the European countries with the highest
MRSA rate according to data from the EARS-Net (around
40%) and with the highest density of pig-livestock farming
[16]. This is the first study evaluating the prevalence of
LA-MRSA in the general population, in carriage and in-
fections, in our country.
The presence of LA-MRSA in the general population
confirms the importance of the animal reservoir and in-
dicate the need for preventive measures to control the
extent of LA-MRSA spread.
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